Advertisement

Role of Ethnic Differences in Mediators of Energy Balance

  • Sarah S. Cohen
  • Loren LipworthEmail author
Chapter
Part of the Energy Balance and Cancer book series (EBAC, volume 9)

Abstract

The rapid increase in the prevalence of obesity in the USA in the past 30 years has many health implications. Obesity is strongly associated with incidence and mortality of several common cancers including post-menopausal breast cancer, renal cell cancer, colorectal cancer, prostate cancer, and endometrial cancer. Obesity patterns in the USA vary substantially by race, particularly for women, with black women having a higher prevalence of obesity than white women. Moreover, black men and women experience higher incidence and mortality for many common cancers and cardiovascular disease.

Keywords

Racial differences—insulin IGF-1 Racial differences—adiponectin Racial differences—leptin Racial differences—sex steroid hormones Racial differences—inflammation 

References

  1. 1.
    Pi-Sunyer FX (2000) Obesity: criteria and classification. Proc Nutr Soc 59(4):505–509PubMedGoogle Scholar
  2. 2.
    Bray GA (2004) Medical consequences of obesity. J Clin Endocrinol Metab 89(6):2583–2589PubMedGoogle Scholar
  3. 3.
    Snijder MB, van Dam RM, Visser M, Seidell JC (2006) What aspects of body fat are particularly hazardous and how do we measure them? Int J Epidemiol 35(1):83–92PubMedGoogle Scholar
  4. 4.
    Willett WC (1998) Nutritional epidemiology, 2nd edn. Oxford University Press, New York, NYGoogle Scholar
  5. 5.
    World Health Organization (1997) Obesity: preventing and managing the global epidemic. Report of a WHO consultation on obesity. WHO, GenevaGoogle Scholar
  6. 6.
    (1998) Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Arch Intern Med 158(17):1855–1867Google Scholar
  7. 7.
    Hu FB (2008) Obesity epidemiology, 1st edn. Oxford University Press, New York, NYGoogle Scholar
  8. 8.
    Lovejoy JC, de la Bretonne JA, Klemperer M, Tulley R (1996) Abdominal fat distribution and metabolic risk factors: effects of race. Metabolism 45(9):1119–1124PubMedGoogle Scholar
  9. 9.
    Evans EM, Rowe DA, Racette SB, Ross KM, McAuley E (2006) Is the current BMI obesity classification appropriate for black and white postmenopausal women? Int J Obes (Lond) 30(5):837–843Google Scholar
  10. 10.
    Gallagher D, Visser M, Sepulveda D, Pierson RN, Harris T, Heymsfield SB (1996) How useful is body mass index for comparison of body fatness across age, sex, and ethnic groups? Am J Epidemiol 143(3):228–239PubMedGoogle Scholar
  11. 11.
    Wagner DR, Heyward VH (2000) Measures of body composition in blacks and whites: a comparative review. Am J Clin Nutr 71(6):1392–1402PubMedGoogle Scholar
  12. 12.
    Flegal KM, Carroll MD, Ogden CL, Curtin LR (2010) Prevalence and trends in obesity among US adults, 1999–2008. JAMA 303(3):235–241PubMedGoogle Scholar
  13. 13.
    Flegal KM, Carroll MD, Ogden CL, Johnson CL (2002) Prevalence and trends in obesity among US adults, 1999–2000. JAMA 288(14):1723–1727PubMedGoogle Scholar
  14. 14.
    Ogden CL, Carroll MD, Kit BK, Flegal KM (2013) Prevalence of obesity among adults: United States, 2011–2012. NCHS Data Brief No. 131. Hyattsville, MDGoogle Scholar
  15. 15.
    Ogden CL, Yanovski SZ, Carroll MD, Flegal KM (2007) The epidemiology of obesity. Gastroenterology 132(6):2087–2102PubMedGoogle Scholar
  16. 16.
    Hill JO, Melanson EL (1999) Overview of the determinants of overweight and obesity: current evidence and research issues. Med Sci Sports Exerc 31(11 Suppl):S515–S521PubMedGoogle Scholar
  17. 17.
    Kumanyika S (1987) Obesity in black women. Epidemiol Rev 9:31–50PubMedGoogle Scholar
  18. 18.
    Parker JD, Abrams B (1993) Differences in postpartum weight retention between black and white mothers. Obstet Gynecol 81(5 Pt 1):768–774PubMedGoogle Scholar
  19. 19.
    Patel KA, Schlundt DG (2001) Impact of moods and social context on eating behavior. Appetite 36(2):111–118PubMedGoogle Scholar
  20. 20.
    Hill JO, Wyatt HR, Reed GW, Peters JC (2003) Obesity and the environment: where do we go from here? Science 299:853–855PubMedGoogle Scholar
  21. 21.
    Department of Health and Human Services (2008) Physical activity guidelines advisory committee physical activity guidelines advisory committee report, Department of Health and Human Services, Washington, DCGoogle Scholar
  22. 22.
    Centers for Disease Control and Prevention (2005) Adult participation in recommended levels of physical activity-United States, 2001 and 2003. Morb Mortal Wkly Rep 54:1208–1212Google Scholar
  23. 23.
    Ahmed NU, Smith GL, Flores AM, Pamies RJ, Mason HR, Woods KF, Stain SC (2005) Racial/ethnic disparity and predictors of leisure-time physical activity among U.S. men. Ethn Dis 15(1):40–52PubMedGoogle Scholar
  24. 24.
    Crespo CJ, Smit E, Andersen RE, Carter-Pokras O, Ainsworth BE (2000) Race/ethnicity, social class and their relation to physical inactivity during leisure time: results from the Third National Health and Nutrition Examination Survey, 1988–1994. Am J Prev Med 18(1):46–53PubMedGoogle Scholar
  25. 25.
    Macera CA, Ham SA, Yore MM, Jones DA, Ainsworth BE, Kimsey CD, Kohl HW 3rd (2005) Prevalence of physical activity in the United States: behavioral risk factor surveillance system, 2001. Prev Chronic Dis 2(2):A17PubMedPubMedCentralGoogle Scholar
  26. 26.
    Kimm SY, Glynn NW, Kriska AM, Barton BA, Kronsberg SS, Daniels SR, Crawford PB, Sabry ZI, Liu K (2002) Decline in physical activity in black girls and white girls during adolescence. N Engl J Med 347(10):709–715PubMedGoogle Scholar
  27. 27.
    He XZ, Baker DW (2005) Differences in leisure-time, household, and work-related physical activity by race, ethnicity, and education. J Gen Intern Med 20(3):259–266PubMedPubMedCentralGoogle Scholar
  28. 28.
    Marshall SJ, Jones DA, Ainsworth BE, Reis JP, Levy SS, Macera CA (2007) Race/ethnicity, social class, and leisure-time physical inactivity. Med Sci Sports Exerc 39(1):44–51PubMedGoogle Scholar
  29. 29.
    Jebb SA (2007) Dietary determinants of obesity. Obes Rev 8(Suppl 1):93–97PubMedGoogle Scholar
  30. 30.
    Bowman SA, Vinyard BT (2004) Fast food consumption of U.S. adults: impact on energy and nutrient intakes and overweight status. J Am Coll Nutr 23(2):163–168PubMedGoogle Scholar
  31. 31.
    Bray GA, Nielsen SJ, Popkin BM (2004) Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr 79(4):537–543PubMedGoogle Scholar
  32. 32.
    Bray GA, Paeratakul S, Popkin BM (2004) Dietary fat and obesity: a review of animal, clinical and epidemiological studies. Physiol Behav 83(4):549–555PubMedGoogle Scholar
  33. 33.
    Isganaitis E, Lustig RH (2005) Fast food, central nervous system insulin resistance, and obesity. Arterioscler Thromb Vasc Biol 25(12):2451–2462PubMedGoogle Scholar
  34. 34.
    Drewnowski A (2007) The real contribution of added sugars and fats to obesity. Epidemiol Rev 29:160–171PubMedGoogle Scholar
  35. 35.
    Lewis CE, Smith DE, Wallace DD, Williams OD, Bild DE, Jacobs DR Jr (1997) Seven-year trends in body weight and associations with lifestyle and behavioral characteristics in black and white young adults: the CARDIA study. Am J Public Health 87(4):635–642PubMedPubMedCentralGoogle Scholar
  36. 36.
    Linne Y, Dye L, Barkeling B, Rossner S (2003) Weight development over time in parous women—the SPAWN study—15 years follow-up. Int J Obes Relat Metab Disord 27(12):1516–1522PubMedGoogle Scholar
  37. 37.
    Brown JE, Kaye SA, Folsom AR (1992) Parity-related weight change in women. Int J Obes Relat Metab Disord 16(9):627–631PubMedGoogle Scholar
  38. 38.
    Williamson DF, Madans J, Pamuk E, Flegal KM, Kendrick JS, Serdula MK (1994) A prospective study of childbearing and 10-year weight gain in US white women 25 to 45 years of age. Int J Obes Relat Metab Disord 18(8):561–569PubMedGoogle Scholar
  39. 39.
    Harris HE, Ellison GT, Holliday M (1997) Is there an independent association between parity and maternal weight gain? Ann Hum Biol 24(6):507–519PubMedGoogle Scholar
  40. 40.
    Lahmann PH, Lissner L, Gullberg B, Berglund G (2000) Sociodemographic factors associated with long-term weight gain, current body fatness and central adiposity in Swedish women. Int J Obes Relat Metab Disord 24(6):685–694PubMedGoogle Scholar
  41. 41.
    Bastian LA, West NA, Corcoran C, Munger RG (2005) Number of children and the risk of obesity in older women. Prev Med 40(1):99–104PubMedGoogle Scholar
  42. 42.
    Keppel KG, Taffel SM (1993) Pregnancy-related weight gain and retention: implications of the 1990 Institute of Medicine guidelines. Am J Public Health 83(8):1100–1103PubMedPubMedCentralGoogle Scholar
  43. 43.
    Smith DE, Lewis CE, Caveny JL, Perkins LL, Burke GL, Bild DE (1994) Longitudinal changes in adiposity associated with pregnancy. The CARDIA Study. Coronary Artery Risk Development in Young Adults Study. JAMA 271(22):1747–1751PubMedGoogle Scholar
  44. 44.
    Lee SK, Sobal J, Frongillo EA, Olson CM, Wolfe WS (2005) Parity and body weight in the United States: differences by race and size of place of residence. Obes Res 13(7):1263–1269PubMedGoogle Scholar
  45. 45.
    Cohen SS, Larson CO, Matthews CE, Buchowski MS, Signorello LB, Hargreaves MK, Blot WJ (2009) Parity and breastfeeding in relation to obesity among black and white women in the southern community cohort study. J Womens Health (Larchmt) 18(9):1323–1332Google Scholar
  46. 46.
    National Center for Health Statistics (2006) Health, United States 2006, with Chartbook on Trends in the Health of Americans. Hyattsville, MDGoogle Scholar
  47. 47.
    Szklarska A, Jankowska EA (2003) Independent effects of social position and parity on body mass index among Polish adult women. J Biosoc Sci 35(4):575–583PubMedGoogle Scholar
  48. 48.
    Bernstein L, Teal CR, Joslyn S, Wilson J (2003) Ethnicity-related variation in breast cancer risk factors. Cancer 97(1 Suppl):222–229PubMedGoogle Scholar
  49. 49.
    Ludington-Hoe SM, McDonald PE, Satyshur R (2002) Breastfeeding in African-American women. J Natl Black Nurses Assoc 13(1):56–64PubMedGoogle Scholar
  50. 50.
    Ohlin A, Rossner S (1996) Factors related to body weight changes during and after pregnancy: the Stockholm Pregnancy and Weight Development Study. Obes Res 4(3):271–276PubMedGoogle Scholar
  51. 51.
    Rooney BL, Schauberger CW (2002) Excess pregnancy weight gain and long-term obesity: one decade later. Obstet Gynecol 100(2):245–252PubMedGoogle Scholar
  52. 52.
    McLaren L (2007) Socioeconomic status and obesity. Epidemiol Rev 29:29–48PubMedGoogle Scholar
  53. 53.
    Robert SA, Reither EN (2004) A multilevel analysis of race, community disadvantage, and body mass index among adults in the US. Soc Sci Med 59(12):2421–2434PubMedGoogle Scholar
  54. 54.
    Wang Y, Beydoun MA (2007) The obesity epidemic in the United States—gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev 29:6–28PubMedGoogle Scholar
  55. 55.
    Zhang Q, Wang Y (2004) Trends in the association between obesity and socioeconomic status in U.S. adults: 1971 to 2000. Obes Res 12(10):1622–1632PubMedGoogle Scholar
  56. 56.
    Zhang Q, Wang Y (2004) Socioeconomic inequality of obesity in the United States: do gender, age, and ethnicity matter? Soc Sci Med 58(6):1171–1180PubMedGoogle Scholar
  57. 57.
    U.S. Cancer Statistics Working Group (2009) United States cancer statistics: 1999–2005 incidence and mortality web-based report, US Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, Atlanta, GAGoogle Scholar
  58. 58.
    U.S. Cancer Statistics Working Group (2013) United States cancer statistics: 1999–2010 incidence and mortality web-based report, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, Atlanta, GAGoogle Scholar
  59. 59.
    Calle EE, Thun MJ (2004) Obesity and cancer. Oncogene 23(38):6365–6378PubMedGoogle Scholar
  60. 60.
    Abu-Abid S, Szold A, Klausner J (2002) Obesity and cancer. J Med 33(1–4):73–86PubMedGoogle Scholar
  61. 61.
    Bianchini F, Kaaks R, Vainio H (2002) Overweight, obesity, and cancer risk. Lancet Oncol 3(9):565–574PubMedGoogle Scholar
  62. 62.
    Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348(17):1625–1638PubMedGoogle Scholar
  63. 63.
    IARC (2002) IARC handbooks of cancer prevention. Weight control and physical activity. International Agency for Research on Cancer, LyonGoogle Scholar
  64. 64.
    Anderson GL, Neuhouser ML (2012) Obesity and the risk for premenopausal and postmenopausal breast cancer. Cancer Prev Res (Phila) 5(4):515–521Google Scholar
  65. 65.
    Suzuki R, Orsini N, Saji S, Key TJ, Wolk A (2009) Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status—a meta-analysis. Int J Cancer 124(3):698–712PubMedGoogle Scholar
  66. 66.
    Ursin G, Longnecker MP, Haile RW, Greenland S (1995) A meta-analysis of body mass index and risk of premenopausal breast cancer. Epidemiology 6(2):137–141PubMedGoogle Scholar
  67. 67.
    van den Brandt PA, Spiegelman D, Yaun SS, Adami HO, Beeson L, Folsom AR, Fraser G, Goldbohm RA, Graham S, Kushi L, Marshall JR, Miller AB, Rohan T, Smith-Warner SA, Speizer FE, Willett WC, Wolk A, Hunter DJ (2000) Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol 152(6):514–527PubMedGoogle Scholar
  68. 68.
    Cecchini RS, Costantino JP, Cauley JA, Cronin WM, Wickerham DL, Land SR, Weissfeld JL, Wolmark N (2012) Body mass index and the risk for developing invasive breast cancer among high-risk women in NSABP P-1 and STAR breast cancer prevention trials. Cancer Prev Res (Phila) 5(4):583–592Google Scholar
  69. 69.
    Millikan RC, Newman B, Tse CK, Moorman PG, Conway K, Dressler LG, Smith LV, Labbok MH, Geradts J, Bensen JT, Jackson S, Nyante S, Livasy C, Carey L, Earp HS, Perou CM (2008) Epidemiology of basal-like breast cancer. Breast Cancer Res Treat 109(1):123–139PubMedPubMedCentralGoogle Scholar
  70. 70.
    Yang XR, Chang-Claude J, Goode EL, Couch FJ, Nevanlinna H, Milne RL, Gaudet M, Schmidt MK, Broeks A, Cox A, Fasching PA, Hein R, Spurdle AB, Blows F, Driver K, Flesch-Janys D, Heinz J, Sinn P, Vrieling A, Heikkinen T, Aittomaki K, Heikkila P, Blomqvist C, Lissowska J, Peplonska B, Chanock S, Figueroa J, Brinton L, Hall P, Czene K, Humphreys K, Darabi H, Liu J, Veer LJ V 't, van Leeuwen FE, Andrulis IL, Glendon G, Knight JA, Mulligan AM, O’Malley FP, Weerasooriya N, John EM, Beckmann MW, Hartmann A, Weihbrecht SB, Wachter DL, Jud SM, Loehberg CR, Baglietto L, English DR, Giles GG, McLean CA, Severi G, Lambrechts D, Vandorpe T, Weltens C, Paridaens R, Smeets A, Neven P, Wildiers H, Wang X, Olson JE, Cafourek V, Fredericksen Z, Kosel M, Vachon C, Cramp HE, Connley D, Cross SS, Balasubramanian SP, Reed MW, Dork T, Bremer M, Meyer A, Karstens JH, Ay A, Park-Simon TW, Hillemanns P, Arias Perez JI, Menendez Rodriguez P, Zamora P, Benitez J, Ko YD, Fischer HP, Hamann U, Pesch B, Bruning T, Justenhoven C, Brauch H, Eccles DM, Tapper WJ, Gerty SM, Sawyer EJ, Tomlinson IP, Jones A, Kerin M, Miller N, McInerney N, Anton-Culver H, Ziogas A, Shen CY, Hsiung CN, Wu PE, Yang SL, Yu JC, Chen ST, Hsu GC, Haiman CA, Henderson BE, Le Marchand L, Kolonel LN, Lindblom A, Margolin S, Jakubowska A, Lubinski J, Huzarski T, Byrski T, Gorski B, Gronwald J, Hooning MJ, Hollestelle A, van den Ouweland AM, Jager A, Kriege M, Tilanus-Linthorst MM, Collee M, Wang-Gohrke S, Pylkas K, Jukkola-Vuorinen A, Mononen K, Grip M, Hirvikoski P, Winqvist R, Mannermaa A, Kosma VM, Kauppinen J, Kataja V, Auvinen P, Soini Y, Sironen R, Bojesen SE, Orsted DD, Kaur-Knudsen D, Flyger H, Nordestgaard BG, Holland H, Chenevix-Trench G, Manoukian S, Barile M, Radice P, Hankinson SE, Hunter DJ, Tamimi R, Sangrajrang S, Brennan P, McKay J, Odefrey F, Gaborieau V, Devilee P, Huijts PE, Tollenaar RA, Seynaeve C, Dite GS, Apicella C, Hopper JL, Hammet F, Tsimiklis H, Smith LD, Southey MC, Humphreys MK, Easton D, Pharoah P, Sherman ME, Garcia-Closas M (2011) Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst 103(3):250–263PubMedPubMedCentralGoogle Scholar
  71. 71.
    Turkoz FP, Solak M, Petekkaya I, Keskin O, Kertmen N, Sarici F, Arik Z, Babacan T, Ozisik Y, Altundag K (2013) Association between common risk factors and molecular subtypes in breast cancer patients. Breast 22(3):344–350PubMedGoogle Scholar
  72. 72.
    Petekkaya I, Sahin U, Gezgen G, Solak M, Yuce D, Dizdar O, Arslan C, Ayyildiz V, Altundag K (2013) Association of breast cancer subtypes and body mass index. Tumori 99(2):129–133PubMedGoogle Scholar
  73. 73.
    Desantis C, Ma J, Bryan L, Jemal A (2013) Breast cancer statistics, 2013. CA Cancer J Clin 64:52–62PubMedGoogle Scholar
  74. 74.
    Bandera EV, Chandran U, Zirpoli G, Gong Z, McCann SE, Hong CC, Ciupak G, Pawlish K, Ambrosone CB (2013) Body fatness and breast cancer risk in women of African ancestry. BMC Cancer 13:475PubMedPubMedCentralGoogle Scholar
  75. 75.
    Hall IJ, Newman B, Millikan RC, Moorman PG (2000) Body size and breast cancer risk in black women and white women: the Carolina Breast Cancer Study. Am J Epidemiol 151(8):754–764PubMedGoogle Scholar
  76. 76.
    Harvie M, Hooper L, Howell AH (2003) Central obesity and breast cancer risk: a systematic review. Obes Rev 4(3):157–173PubMedGoogle Scholar
  77. 77.
    Mayberry RM (1994) Age-specific patterns of association between breast cancer and risk factors in black women, ages 20 to 39 and 40 to 54. Ann Epidemiol 4(3):205–213PubMedGoogle Scholar
  78. 78.
    Schatzkin A, Palmer JR, Rosenberg L, Helmrich SP, Miller DR, Kaufman DW, Lesko SM, Shapiro S (1987) Risk factors for breast cancer in black women. J Natl Cancer Inst 78(2):213–217PubMedGoogle Scholar
  79. 79.
    Zhu K, Caulfield J, Hunter S, Roland CL, Payne-Wilks K, Texter L (2005) Body mass index and breast cancer risk in African American women. Ann Epidemiol 15(2):123–128PubMedGoogle Scholar
  80. 80.
    Palmer JR, Adams-Campbell LL, Boggs DA, Wise LA, Rosenberg L (2007) A prospective study of body size and breast cancer in black women. Cancer Epidemiol Biomarkers Prev 16(9):1795–1802PubMedGoogle Scholar
  81. 81.
    John EM, Sangaramoorthy M, Phipps AI, Koo J, Horn-Ross PL (2011) Adult body size, hormone receptor status, and premenopausal breast cancer risk in a multiethnic population: the San Francisco Bay Area breast cancer study. Am J Epidemiol 173(2):201–216PubMedPubMedCentralGoogle Scholar
  82. 82.
    Stephenson GD, Rose DP (2003) Breast cancer and obesity: an update. Nutr Cancer 45(1):1–16PubMedGoogle Scholar
  83. 83.
    Carmichael AR, Bates T (2004) Obesity and breast cancer: a review of the literature. Breast 13(2):85–92PubMedGoogle Scholar
  84. 84.
    Morimoto LM, White E, Chen Z, Chlebowski RT, Hays J, Kuller L, Lopez AM, Manson J, Margolis KL, Muti PC, Stefanick ML, McTiernan A (2002) Obesity, body size, and risk of postmenopausal breast cancer: the Women’s Health Initiative (United States). Cancer Causes Control 13(8):741–751PubMedGoogle Scholar
  85. 85.
    Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM (1995) Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269(5223):543–546PubMedGoogle Scholar
  86. 86.
    White KK, Park SY, Kolonel LN, Henderson BE, Wilkens LR (2012) Body size and breast cancer risk: the Multiethnic Cohort. Int J Cancer 131(5):E705–E716PubMedGoogle Scholar
  87. 87.
    Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. CA Cancer J Clin 64(1):9–29Google Scholar
  88. 88.
    Jemal A, Thun MJ, Ries LA, Howe HL, Weir HK, Center MM, Ward E, Wu XC, Eheman C, Anderson R, Ajani UA, Kohler B, Edwards BK (2008) Annual report to the nation on the status of cancer, 1975–2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst 100(23):1672–1694PubMedPubMedCentralGoogle Scholar
  89. 89.
    Lipworth L, McLaughlin JK, Tarone RE, Blot WJ (2011) Renal cancer paradox: higher incidence but not higher mortality among African-Americans. Eur J Cancer Prev 20(4):331–333PubMedPubMedCentralGoogle Scholar
  90. 90.
    Lipworth L, Tarone RE, McLaughlin JK (2011) Renal cell cancer among African Americans: an epidemiologic review. BMC Cancer 11:133PubMedPubMedCentralGoogle Scholar
  91. 91.
    Desantis C, Naishadham D, Jemal A (2013) Cancer statistics for African Americans, 2013. CA Cancer J Clin 63:151–166PubMedGoogle Scholar
  92. 92.
    Sankin A, Cohen J, Wang H, Macchia RJ, Karanikolas N (2011) Rate of renal cell carcinoma subtypes in different races. Int Braz J Urol 37(1):29–32, discussion 33–24PubMedGoogle Scholar
  93. 93.
    Ildaphonse G, George PS, Mathew A (2009) Obesity and kidney cancer risk in men: a meta-analysis (1992–2008). Asian Pac J Cancer Prev 10(2):279–286PubMedGoogle Scholar
  94. 94.
    Mathew A, George PS, Ildaphonse G (2009) Obesity and kidney cancer risk in women: a meta-analysis (1992–2008). Asian Pac J Cancer Prev 10(3):471–478PubMedGoogle Scholar
  95. 95.
    Klinghoffer Z, Yang B, Kapoor A, Pinthus JH (2009) Obesity and renal cell carcinoma: epidemiology, underlying mechanisms and management considerations. Expert Rev Anticancer Ther 9(7):975–987PubMedGoogle Scholar
  96. 96.
    Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371(9612):569–578PubMedGoogle Scholar
  97. 97.
    Samanic C, Gridley G, Chow WH, Lubin J, Hoover RN, Fraumeni JF Jr (2004) Obesity and cancer risk among white and black United States veterans. Cancer Causes Control 15(1):35–43PubMedGoogle Scholar
  98. 98.
    Purdue MP, Moore LE, Merino MJ, Boffetta P, Colt JS, Schwartz KL, Bencko V, Davis FG, Graubard BI, Janout V, Ruterbusch JJ, Beebe-Dimmer J, Cote ML, Shuch B, Mates D, Hofmann JN, Foretova L, Rothman N, Szeszenia-Dabrowska N, Matveev V, Wacholder S, Zaridze D, Linehan WM, Brennan P, Chow WH (2012) An investigation of risk factors for renal cell carcinoma by histologic subtype in two case-control studies. Int J Cancer 132:2640–2647Google Scholar
  99. 99.
    Arcidiacono B, Iiritano S, Nocera A, Possidente K, Nevolo MT, Ventura V, Foti D, Chiefari E, Brunetti A (2012) Insulin resistance and cancer risk: an overview of the pathogenetic mechanisms. Exp Diabetes Res 2012:789174PubMedPubMedCentralGoogle Scholar
  100. 100.
    Morris PG, Hudis CA, Giri D, Morrow M, Falcone DJ, Zhou XK, Du B, Brogi E, Crawford CB, Kopelovich L, Subbaramaiah K, Dannenberg AJ (2011) Inflammation and increased aromatase expression occur in the breast tissue of obese women with breast cancer. Cancer Prev Res (Phila) 4(7):1021–1029Google Scholar
  101. 101.
    Hursting SD, Digiovanni J, Dannenberg AJ, Azrad M, Leroith D, Demark-Wahnefried W, Kakarala M, Brodie A, Berger NA (2012) Obesity, energy balance, and cancer: new opportunities for prevention. Cancer Prev Res (Phila) 5(11):1260–1272Google Scholar
  102. 102.
    Renehan AG, Roberts DL, Dive C (2008) Obesity and cancer: pathophysiological and biological mechanisms. Arch Physiol Biochem 114(1):71–83PubMedGoogle Scholar
  103. 103.
    Pollak M (2008) Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer 8(12):915–928PubMedGoogle Scholar
  104. 104.
    Douglas JB, Silverman DT, Pollak MN, Tao Y, Soliman AS, Stolzenberg-Solomon RZ (2010) Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev 19(9):2298–2306PubMedPubMedCentralGoogle Scholar
  105. 105.
    Braun S, Bitton-Worms K, LeRoith D (2011) The link between the metabolic syndrome and cancer. Int J Biol Sci 7(7):1003–1015PubMedPubMedCentralGoogle Scholar
  106. 106.
    Wysocki PJ, Wierusz-Wysocka B (2010) Obesity, hyperinsulinemia and breast cancer: novel targets and a novel role for metformin. Expert Rev Mol Diagn 10(4):509–519PubMedGoogle Scholar
  107. 107.
    Fowke JH, Matthews CE, Yu H, Cai Q, Cohen S, Buchowski MS, Zheng W, Blot WJ (2010) Racial differences in the association between body mass index and serum IGF1, IGF2, and IGFBP3. Endocr Relat Cancer 17(1):51–60PubMedPubMedCentralGoogle Scholar
  108. 108.
    Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Rohan TE, Manson JE, Li J, Ho GY, Xue X, Anderson GL, Kaplan RC, Harris TG, Howard BV, Wylie-Rosett J, Burk RD, Strickler HD (2009) Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 101(1):48–60PubMedPubMedCentralGoogle Scholar
  109. 109.
    Kaaks R, Lundin E, Rinaldi S, Manjer J, Biessy C, Soderberg S, Lenner P, Janzon L, Riboli E, Berglund G, Hallmans G (2002) Prospective study of IGF-I, IGF-binding proteins, and breast cancer risk, in northern and southern Sweden. Cancer Causes Control 13(4):307–316PubMedGoogle Scholar
  110. 110.
    Keinan-Boker L, Bueno De Mesquita HB, Kaaks R, Van Gils CH, Van Noord PA, Rinaldi S, Riboli E, Seidell JC, Grobbee DE, Peeters PH (2003) Circulating levels of insulin-like growth factor I, its binding proteins -1,-2, -3, C-peptide and risk of postmenopausal breast cancer. Int J Cancer 106(1):90–95PubMedGoogle Scholar
  111. 111.
    Renehan AG, Egger M, Minder C, O'Dwyer ST, Shalet SM, Zwahlen M (2005) IGF-I, IGF binding protein-3 and breast cancer risk: comparison of 3 meta-analyses. Int J Cancer 115(6):1006–1007, author reply 1008PubMedGoogle Scholar
  112. 112.
    Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M (2004) Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363(9418):1346–1353PubMedGoogle Scholar
  113. 113.
    Shi R, Yu H, McLarty J, Glass J (2004) IGF-I and breast cancer: a meta-analysis. Int J Cancer 111(3):418–423PubMedGoogle Scholar
  114. 114.
    Sugumar A, Liu YC, Xia Q, Koh YS, Matsuo K (2004) Insulin-like growth factor (IGF)-I and IGF-binding protein 3 and the risk of premenopausal breast cancer: a meta-analysis of literature. Int J Cancer 111(2):293–297PubMedGoogle Scholar
  115. 115.
    Verheus M, Peeters PH, Rinaldi S, Dossus L, Biessy C, Olsen A, Tjonneland A, Overvad K, Jeppesen M, Clavel-Chapelon F, Tehard B, Nagel G, Linseisen J, Boeing H, Lahmann PH, Arvaniti A, Psaltopoulou T, Trichopoulou A, Palli D, Tumino R, Panico S, Sacerdote C, Sieri S, van Gils CH, Bueno-de-Mesquita BH, Gonzalez CA, Ardanaz E, Larranaga N, Garcia CM, Navarro C, Quiros JR, Key T, Allen N, Bingham S, Khaw KT, Slimani N, Riboli E, Kaaks R (2006) Serum C-peptide levels and breast cancer risk: results from the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 119(3):659–667PubMedGoogle Scholar
  116. 116.
    Key TJ, Appleby PN, Reeves GK, Roddam AW (2010) Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol 11(6):530–542PubMedGoogle Scholar
  117. 117.
    Schernhammer ES, Holly JM, Pollak MN, Hankinson SE (2005) Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 14(3):699–704PubMedGoogle Scholar
  118. 118.
    Maiti B, Kundranda MN, Spiro TP, Daw HA (2010) The association of metabolic syndrome with triple-negative breast cancer. Breast Cancer Res Treat 121(2):479–483PubMedGoogle Scholar
  119. 119.
    Pichard C, Plu-Bureau G, Neves ECM, Gompel A (2008) Insulin resistance, obesity and breast cancer risk. Maturitas 60(1):19–30PubMedGoogle Scholar
  120. 120.
    Kellerer M, von Eye CH, Muhlhofer A, Capp E, Mosthaf L, Bock S, Petrides PE, Haring HU (1995) Insulin- and insulin-like growth-factor-I receptor tyrosine-kinase activities in human renal carcinoma. Int J Cancer 62(5):501–507PubMedGoogle Scholar
  121. 121.
    Rosendahl A, Forsberg G (2004) Influence of IGF-IR stimulation or blockade on proliferation of human renal cell carcinoma cell lines. Int J Oncol 25(5):1327–1336PubMedGoogle Scholar
  122. 122.
    Rosendahl AH, Forsberg G (2006) IGF-I and IGFBP-3 augment transforming growth factor-beta actions in human renal carcinoma cells. Kidney Int 70(9):1584–1590PubMedGoogle Scholar
  123. 123.
    Cheung CW, Vesey DA, Nicol DL, Johnson DW (2004) The roles of IGF-I and IGFBP-3 in the regulation of proximal tubule, and renal cell carcinoma cell proliferation. Kidney Int 65(4):1272–1279PubMedGoogle Scholar
  124. 124.
    Ramp U, Jaquet K, Reinecke P, Schardt C, Friebe U, Nitsch T, Marx N, Gabbert HE, Gerharz CD (1997) Functional intactness of stimulatory and inhibitory autocrine loops in human renal carcinoma cell lines of the clear cell type. J Urol 157(6):2345–2350PubMedGoogle Scholar
  125. 125.
    Schips L, Zigeuner R, Ratschek M, Rehak P, Ruschoff J, Langner C (2004) Analysis of insulin-like growth factors and insulin-like growth factor I receptor expression in renal cell carcinoma. Am J Clin Pathol 122(6):931–937PubMedGoogle Scholar
  126. 126.
    Liao LM, Weinstein SJ, Pollak M, Li Z, Virtamo J, Albanes D, Chow WH, Purdue MP (2013) Prediagnostic circulating adipokine concentrations and risk of renal cell carcinoma in male smokers. Carcinogenesis 34(1):109–112PubMedPubMedCentralGoogle Scholar
  127. 127.
    Major JM, Pollak MN, Snyder K, Virtamo J, Albanes D (2010) Insulin-like growth factors and risk of kidney cancer in men. Br J Cancer 103(1):132–135PubMedPubMedCentralGoogle Scholar
  128. 128.
    Kaaks R, Rinaldi S, Key TJ, Berrino F, Peeters PH, Biessy C, Dossus L, Lukanova A, Bingham S, Khaw KT, Allen NE, Bueno-de-Mesquita HB, van Gils CH, Grobbee D, Boeing H, Lahmann PH, Nagel G, Chang-Claude J, Clavel-Chapelon F, Fournier A, Thiebaut A, Gonzalez CA, Quiros JR, Tormo MJ, Ardanaz E, Amiano P, Krogh V, Palli D, Panico S, Tumino R, Vineis P, Trichopoulou A, Kalapothaki V, Trichopoulos D, Ferrari P, Norat T, Saracci R, Riboli E (2005) Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer 12(4):1071–1082PubMedGoogle Scholar
  129. 129.
    Key T, Appleby P, Barnes I, Reeves G (2002) Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 94(8):606–616PubMedGoogle Scholar
  130. 130.
    Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE (2004) Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst 96(24):1856–1865PubMedGoogle Scholar
  131. 131.
    Catalano MG, Frairia R, Boccuzzi G, Fortunati N (2005) Sex hormone-binding globulin antagonizes the anti-apoptotic effect of estradiol in breast cancer cells. Mol Cell Endocrinol 230(1–2):31–37PubMedGoogle Scholar
  132. 132.
    Bezemer ID, Rinaldi S, Dossus L, Gils CH, Peeters PH, Noord PA, Bueno-de-Mesquita HB, Johnsen SP, Overvad K, Olsen A, Tjonneland A, Boeing H, Lahmann PH, Linseisen J, Nagel G, Allen N, Roddam A, Bingham S, Khaw KT, Kesse E, Tehard B, Clavel-Chapelon F, Agudo A, Ardanaz E, Quiros JR, Amiano P, Martinez-Garcia C, Tormo MJ, Pala V, Panico S, Vineis P, Palli D, Tumino R, Trichopoulou A, Baibas N, Zilis D, Hemon B, Norat T, Riboli E, Kaaks R (2005) C-peptide, IGF-I, sex-steroid hormones and adiposity: a cross-sectional study in healthy women within the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Causes Control 16(5):561–572PubMedGoogle Scholar
  133. 133.
    Pinheiro SP, Holmes MD, Pollak MN, Barbieri RL, Hankinson SE (2005) Racial differences in premenopausal endogenous hormones. Cancer Epidemiol Biomarkers Prev 14(9):2147–2153PubMedGoogle Scholar
  134. 134.
    Probst-Hensch NM, Pike MC, McKean-Cowdin R, Stanczyk FZ, Kolonel LN, Henderson BE (2000) Ethnic differences in post-menopausal plasma oestrogen levels: high oestrone levels in Japanese-American women despite low weight. Br J Cancer 82(11):1867–1870PubMedPubMedCentralGoogle Scholar
  135. 135.
    Setiawan VW, Haiman CA, Stanczyk FZ, Le Marchand L, Henderson BE (2006) Racial/ethnic differences in postmenopausal endogenous hormones: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 15(10):1849–1855PubMedGoogle Scholar
  136. 136.
    Woolcott CG, Shvetsov YB, Stanczyk FZ, Wilkens LR, White KK, Caberto C, Henderson BE, Le Marchand L, Kolonel LN, Goodman MT (2010) Plasma sex hormone concentrations and breast cancer risk in an ethnically diverse population of postmenopausal women: the Multiethnic Cohort Study. Endocr Relat Cancer 17(1):125–134PubMedPubMedCentralGoogle Scholar
  137. 137.
    Key TJ (2011) Endogenous oestrogens and breast cancer risk in premenopausal and postmenopausal women. Steroids 76(8):812–815PubMedGoogle Scholar
  138. 138.
    Endogenous Hormones and Breast Cancer Collaborative Group (2013) Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies. Lancet Oncol 14(10):1009–1019Google Scholar
  139. 139.
    Lamon-Fava S, Barnett JB, Woods MN, McCormack C, McNamara JR, Schaefer EJ, Longcope C, Rosner B, Gorbach SL (2005) Differences in serum sex hormone and plasma lipid levels in Caucasian and African-American premenopausal women. J Clin Endocrinol Metab 90(8):4516–4520PubMedGoogle Scholar
  140. 140.
    Randolph JF Jr, Sowers M, Gold EB, Mohr BA, Luborsky J, Santoro N, McConnell DS, Finkelstein JS, Korenman SG, Matthews KA, Sternfeld B, Lasley BL (2003) Reproductive hormones in the early menopausal transition: relationship to ethnicity, body size, and menopausal status. J Clin Endocrinol Metab 88(4):1516–1522PubMedGoogle Scholar
  141. 141.
    Marsh EE, Shaw ND, Klingman KM, Tiamfook-Morgan TO, Yialamas MA, Sluss PM, Hall JE (2011) Estrogen levels are higher across the menstrual cycle in African-American women compared with Caucasian women. J Clin Endocrinol Metab 96(10):3199–3206PubMedPubMedCentralGoogle Scholar
  142. 142.
    Barnett JB, Woods MN, Rosner B, McCormack C, Longcope C, Houser RF Jr, Gorbach SL (2001) Sex hormone levels in premenopausal African-American women with upper and lower body fat phenotypes. Nutr Cancer 41(1–2):47–56PubMedGoogle Scholar
  143. 143.
    Key TJ (1999) Serum oestradiol and breast cancer risk. Endocr Relat Cancer 6(2):175–180PubMedGoogle Scholar
  144. 144.
    Paxton RJ, King DW, Garcia-Prieto C, Connors SK, Hernandez M, Gor BJ, Jones LA (2013) Associations between body size and serum estradiol and sex hormone-binding globulin levels in premenopausal African American women. J Clin Endocrinol Metab 98(3):E485–E490PubMedPubMedCentralGoogle Scholar
  145. 145.
    Waugh DJ, Wilson C (2008) The interleukin-8 pathway in cancer. Clin Cancer Res 14(21):6735–6741PubMedGoogle Scholar
  146. 146.
    Sun X, Casbas-Hernandez P, Bigelow C, Makowski L, Joseph Jerry D, Smith Schneider S, Troester MA (2012) Normal breast tissue of obese women is enriched for macrophage markers and macrophage-associated gene expression. Breast Cancer Res Treat 131(3):1003–1012PubMedPubMedCentralGoogle Scholar
  147. 147.
    Anand SS, Razak F, Yi Q, Davis B, Jacobs R, Vuksan V, Lonn E, Teo K, McQueen M, Yusuf S (2004) C-reactive protein as a screening test for cardiovascular risk in a multiethnic population. Arterioscler Thromb Vasc Biol 24(8):1509–1515PubMedGoogle Scholar
  148. 148.
    Festa A, D’Agostino R Jr, Williams K, Karter AJ, Mayer-Davis EJ, Tracy RP, Haffner SM (2001) The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord 25(10):1407–1415PubMedGoogle Scholar
  149. 149.
    Ford ES (1999) Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care 22(12):1971–1977PubMedGoogle Scholar
  150. 150.
    Esposito K, Pontillo A, Di Palo C, Giugliano G, Masella M, Marfella R, Giugliano D (2003) Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 289(14):1799–1804PubMedGoogle Scholar
  151. 151.
    Puglisi MJ, Fernandez ML (2008) Modulation of C-reactive protein, tumor necrosis factor-alpha, and adiponectin by diet, exercise, and weight loss. J Nutr 138(12):2293–2296PubMedGoogle Scholar
  152. 152.
    Zhang X, Shu XO, Signorello LB, Hargreaves MK, Cai Q, Linton MF, Fazio S, Zheng W, Blot WJ (2008) Correlates of high serum C-reactive protein levels in a socioeconomically disadvantaged population. Dis Markers 24(6):351–359PubMedPubMedCentralGoogle Scholar
  153. 153.
    Vona-Davis L, Rose DP (2007) Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. Endocr Relat Cancer 14(2):189–206PubMedGoogle Scholar
  154. 154.
    Fernandez-Riejos P, Najib S, Santos-Alvarez J, Martin-Romero C, Perez-Perez A, Gonzalez-Yanes C, Sanchez-Margalet V (2010) Role of leptin in the activation of immune cells. Mediators Inflamm 2010:568343PubMedPubMedCentralGoogle Scholar
  155. 155.
    Jarde T, Perrier S, Vasson MP, Caldefie-Chezet F (2011) Molecular mechanisms of leptin and adiponectin in breast cancer. Eur J Cancer 47(1):33–43PubMedGoogle Scholar
  156. 156.
    Devaraj S, Torok N, Dasu MR, Samols D, Jialal I (2008) Adiponectin decreases C-reactive protein synthesis and secretion from endothelial cells: evidence for an adipose tissue-vascular loop. Arterioscler Thromb Vasc Biol 28(7):1368–1374PubMedPubMedCentralGoogle Scholar
  157. 157.
    Crimmins NA, Martin LJ (2007) Polymorphisms in adiponectin receptor genes ADIPOR1 and ADIPOR2 and insulin resistance. Obes Rev 8(5):419–423PubMedGoogle Scholar
  158. 158.
    Takahashi M, Arita Y, Yamagata K, Matsukawa Y, Okutomi K, Horie M, Shimomura I, Hotta K, Kuriyama H, Kihara S, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y (2000) Genomic structure and mutations in adipose-specific gene, adiponectin. Int J Obes Relat Metab Disord 24(7):861–868PubMedGoogle Scholar
  159. 159.
    Jeong YJ, Bong JG, Park SH, Choi JH, Oh HK (2011) Expression of leptin, leptin receptor, adiponectin, and adiponectin receptor in ductal carcinoma in situ and invasive breast cancer. J Breast Cancer 14(2):96–103PubMedPubMedCentralGoogle Scholar
  160. 160.
    Grossmann ME, Cleary MP (2012) The balance between leptin and adiponectin in the control of carcinogenesis—focus on mammary tumorigenesis. Biochimie 94:2164–2171PubMedGoogle Scholar
  161. 161.
    Koerner A, Kratzsch J, Kiess W (2005) Adipocytokines: leptin—the classical, resistin—the controversical, adiponectin—the promising, and more to come. Best Pract Res Clin Endocrinol Metab 19(4):525–546PubMedGoogle Scholar
  162. 162.
    Ronti T, Lupattelli G, Mannarino E (2006) The endocrine function of adipose tissue: an update. Clin Endocrinol (Oxf) 64(4):355–365Google Scholar
  163. 163.
    Swarbrick MM, Havel PJ (2008) Physiological, pharmacological, and nutritional regulation of circulating adiponectin concentrations in humans. Metab Syndr Relat Disord 6(2):87–102PubMedPubMedCentralGoogle Scholar
  164. 164.
    Takeuchi T, Adachi Y, Ohtsuki Y, Furihata M (2007) Adiponectin receptors, with special focus on the role of the third receptor, T-cadherin, in vascular disease. Med Mol Morphol 40(3):115–120PubMedGoogle Scholar
  165. 165.
    Kadowaki T, Yamauchi T (2005) Adiponectin and adiponectin receptors. Endocr Rev 26(3):439–451PubMedGoogle Scholar
  166. 166.
    Bush NC, Darnell BE, Oster RA, Goran MI, Gower BA (2005) Adiponectin is lower among African Americans and is independently related to insulin sensitivity in children and adolescents. Diabetes 54(9):2772–2778PubMedGoogle Scholar
  167. 167.
    Degawa-Yamauchi M, Dilts JR, Bovenkerk JE, Saha C, Pratt JH, Considine RV (2003) Lower serum adiponectin levels in African-American boys. Obes Res 11(11):1384–1390PubMedGoogle Scholar
  168. 168.
    Araneta MR, Barrett-Connor E (2007) Adiponectin and ghrelin levels and body size in normoglycemic Filipino, African-American, and white women. Obesity (Silver Spring) 15(10):2454–2462Google Scholar
  169. 169.
    Ferris WF, Naran NH, Crowther NJ, Rheeder P, van der Merwe L, Chetty N (2005) The relationship between insulin sensitivity and serum adiponectin levels in three population groups. Horm Metab Res 37(11):695–701PubMedGoogle Scholar
  170. 170.
    Steffes MW, Gross MD, Schreiner PJ, Yu X, Hilner JE, Gingerich R, Jacobs DR Jr (2004) Serum adiponectin in young adults—interactions with central adiposity, circulating levels of glucose, and insulin resistance: the CARDIA study. Ann Epidemiol 14(7):492–498PubMedGoogle Scholar
  171. 171.
    Duncan BB, Schmidt MI, Pankow JS, Bang H, Couper D, Ballantyne CM, Hoogeveen RC, Heiss G (2004) Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 53(9):2473–2478PubMedGoogle Scholar
  172. 172.
    Kanaya AM, Wassel Fyr C, Vittinghoff E, Havel PJ, Cesari M, Nicklas B, Harris T, Newman AB, Satterfield S, Cummings SR (2006) Serum adiponectin and coronary heart disease risk in older Black and White Americans. J Clin Endocrinol Metab 91(12):5044–5050PubMedGoogle Scholar
  173. 173.
    Hulver MW, Saleh O, MacDonald KG, Pories WJ, Barakat HA (2004) Ethnic differences in adiponectin levels. Metabolism 53(1):1–3PubMedGoogle Scholar
  174. 174.
    Schutte AE, Huisman HW, Schutte R, Malan L, van Rooyen JM, Malan NT, Schwarz PE (2007) Differences and similarities regarding adiponectin investigated in African and Caucasian women. Eur J Endocrinol 157(2):181–188PubMedGoogle Scholar
  175. 175.
    Wassel Fyr CL, Kanaya AM, Cummings SR, Reich D, Hsueh WC, Reiner AP, Harris TB, Moffett S, Li R, Ding J, Miljkovic-Gacic I, Ziv E (2007) Genetic admixture, adipocytokines, and adiposity in Black Americans: the health, aging, and body composition study. Hum Genet 121(5):615–624PubMedGoogle Scholar
  176. 176.
    Chandran M, Phillips SA, Ciaraldi T, Henry RR (2003) Adiponectin: more than just another fat cell hormone? Diabetes Care 26(8):2442–2450PubMedGoogle Scholar
  177. 177.
    Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, Matsuzawa Y (2000) Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20(6):1595–1599PubMedGoogle Scholar
  178. 178.
    Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257(1):79–83PubMedGoogle Scholar
  179. 179.
    Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, Retzlaff BM, Knopp RH, Brunzell JD, Kahn SE (2003) Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 46(4):459–469PubMedGoogle Scholar
  180. 180.
    Staiger H, Tschritter O, Machann J, Thamer C, Fritsche A, Maerker E, Schick F, Haring HU, Stumvoll M (2003) Relationship of serum adiponectin and leptin concentrations with body fat distribution in humans. Obes Res 11(3):368–372PubMedGoogle Scholar
  181. 181.
    Miljkovic-Gacic I, Wang X, Kammerer CM, Bunker CH, Wheeler VW, Patrick AL, Kuller LH, Evans RW, Zmuda JM (2007) Genetic determination of adiponectin and its relationship with body fat topography in multigenerational families of African heritage. Metabolism 56(2):234–238PubMedPubMedCentralGoogle Scholar
  182. 182.
    Hanley AJ, Bowden D, Wagenknecht LE, Balasubramanyam A, Langfeld C, Saad MF, Rotter JI, Guo X, Chen YD, Bryer-Ash M, Norris JM, Haffner SM (2007) Associations of adiponectin with body fat distribution and insulin sensitivity in nondiabetic hispanics and African-Americans. J Clin Endocrinol Metab 92(7):2665–2671PubMedGoogle Scholar
  183. 183.
    Anubhuti AS (2008) Leptin and its metabolic interactions: an update. Diabetes Obes Metab 10(11):973–993PubMedGoogle Scholar
  184. 184.
    Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372(6505):425–432PubMedGoogle Scholar
  185. 185.
    Auwerx J, Staels B (1998) Leptin. Lancet 351(9104):737–742PubMedGoogle Scholar
  186. 186.
    Sinha MK, Sturis J, Ohannesian J, Magosin S, Stephens T, Heiman ML, Polonsky KS, Caro JF (1996) Ultradian oscillations of leptin secretion in humans. Biochem Biophys Res Commun 228(3):733–738PubMedGoogle Scholar
  187. 187.
    Gautron L, Elmquist JK (2011) Sixteen years and counting: an update on leptin in energy balance. J Clin Invest 121(6):2087–2093PubMedPubMedCentralGoogle Scholar
  188. 188.
    Mente A, Razak F, Blankenberg S, Vuksan V, Davis AD, Miller R, Teo K, Gerstein H, Sharma AM, Yusuf S, Anand SS (2010) Ethnic variation in adiponectin and leptin levels and their association with adiposity and insulin resistance. Diabetes Care 33(7):1629–1634PubMedPubMedCentralGoogle Scholar
  189. 189.
    Cohen SS, Fowke JH, Cai Q, Buchowski MS, Signorello LB, Hargreaves MK, Zheng W, Blot WJ, Matthews CE (2012) Differences in the association between serum leptin levels and body mass index in black and white women: a report from the Southern Community Cohort Study. Ann Nutr Metab 60(2):90–97PubMedPubMedCentralGoogle Scholar
  190. 190.
    Ries LAG, Harkins D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, Clegg L, Eisner MP, Horner MJ, Howlader N, Hayat M, Hankey BF, Edwards BK (2006) SEER cancer statistics review, 1975–2003. National Cancer Institute Bethesda, MD. http://seer.cancer.gov/csr/1975_2003/, based on November 2005 SEER data submission, posted to the SEER web site, 2006Google Scholar
  191. 191.
    Gibbons GH (2004) Physiology, genetics, and cardiovascular disease: focus on African Americans. J Clin Hypertens (Greenwich) 6(4 Suppl 1):11–18Google Scholar
  192. 192.
    Dieudonne MN, Bussiere M, Dos Santos E, Leneveu MC, Giudicelli Y, Pecquery R (2006) Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells. Biochem Biophys Res Commun 345(1):271–279PubMedGoogle Scholar
  193. 193.
    Treeck O, Lattrich C, Juhasz-Boess I, Buchholz S, Pfeiler G, Ortmann O (2008) Adiponectin differentially affects gene expression in human mammary epithelial and breast cancer cells. Br J Cancer 99(8):1246–1250PubMedPubMedCentralGoogle Scholar
  194. 194.
    Arditi JD, Venihaki M, Karalis KP, Chrousos GP (2007) Antiproliferative effect of adiponectin on MCF7 breast cancer cells: a potential hormonal link between obesity and cancer. Horm Metab Res 39(1):9–13PubMedGoogle Scholar
  195. 195.
    Jarde T, Caldefie-Chezet F, Goncalves-Mendes N, Mishellany F, Buechler C, Penault-Llorca F, Vasson MP (2009) Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies. Endocr Relat Cancer 16(4):1197–1210PubMedGoogle Scholar
  196. 196.
    Kang JH, Lee YY, Yu BY, Yang BS, Cho KH, Yoon DK, Roh YK (2005) Adiponectin induces growth arrest and apoptosis of MDA-MB-231 breast cancer cell. Arch Pharm Res 28(11):1263–1269PubMedGoogle Scholar
  197. 197.
    Barb D, Williams CJ, Neuwirth AK, Mantzoros CS (2007) Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence. Am J Clin Nutr 86(3):s858–s866PubMedGoogle Scholar
  198. 198.
    Chen DC, Chung YF, Yeh YT, Chaung HC, Kuo FC, Fu OY, Chen HY, Hou MF, Yuan SS (2006) Serum adiponectin and leptin levels in Taiwanese breast cancer patients. Cancer Lett 237(1):109–114PubMedGoogle Scholar
  199. 199.
    Korner A, Pazaitou-Panayiotou K, Kelesidis T, Kelesidis I, Williams CJ, Kaprara A, Bullen J, Neuwirth A, Tseleni S, Mitsiades N, Kiess W, Mantzoros CS (2006) Total and high molecular weight adiponectin in breast cancer: in vitro and in vivo studies. J Clin Endocrinol Metab 92:1041–1048PubMedGoogle Scholar
  200. 200.
    Mantzoros C, Petridou E, Dessypris N, Chavelas C, Dalamaga M, Alexe DM, Papadiamantis Y, Markopoulos C, Spanos E, Chrousos G, Trichopoulos D (2004) Adiponectin and breast cancer risk. J Clin Endocrinol Metab 89(3):1102–1107PubMedGoogle Scholar
  201. 201.
    Miyoshi Y, Funahashi T, Kihara S, Taguchi T, Tamaki Y, Matsuzawa Y, Noguchi S (2003) Association of serum adiponectin levels with breast cancer risk. Clin Cancer Res 9(15):5699–5704PubMedGoogle Scholar
  202. 202.
    Tian YF, Chu CH, Wu MH, Chang CL, Yang T, Chou YC, Hsu GC, Yu CP, Yu JC, Sun CA (2007) Anthropometric measures, plasma adiponectin, and breast cancer risk. Endocr Relat Cancer 14(3):669–677PubMedGoogle Scholar
  203. 203.
    Kang JH, Yu BY, Youn DS (2007) Relationship of serum adiponectin and resistin levels with breast cancer risk. J Korean Med Sci 22(1):117–121PubMedPubMedCentralGoogle Scholar
  204. 204.
    Tworoger SS, Eliassen AH, Kelesidis T, Colditz GA, Willett WC, Mantzoros C, Hankinson SE (2007) Plasma adiponectin concentrations and risk of incident breast cancer. J Clin Endocrinol Metab 92:1510–1516PubMedGoogle Scholar
  205. 205.
    Liu LY, Wang M, Ma ZB, Yu LX, Zhang Q, Gao DZ, Wang F, Yu ZG (2013) The role of adiponectin in breast cancer: a meta-analysis. PLoS One 8(8):e73183PubMedPubMedCentralGoogle Scholar
  206. 206.
    Vona-Davis L, Howard-McNatt M, Rose DP (2007) Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer. Obes Rev 8(5):395–408PubMedGoogle Scholar
  207. 207.
    Maccio A, Madeddu C (2011) Obesity, inflammation, and postmenopausal breast cancer: therapeutic implications. ScientificWorldJournal 11:2020–2036PubMedPubMedCentralGoogle Scholar
  208. 208.
    Spyridopoulos TN, Dessypris N, Antoniadis AG, Gialamas S, Antonopoulos CN, Katsifoti K, Adami HO, Chrousos GP, Petridou ET (2012) Insulin resistance and risk of renal cell cancer: a case-control study. Hormones (Athens) 11(3):308–315Google Scholar
  209. 209.
    Spyridopoulos TN, Petridou ET, Dessypris N, Terzidis A, Skalkidou A, Deliveliotis C, Chrousos GP (2009) Inverse association of leptin levels with renal cell carcinoma: results from a case-control study. Hormones (Athens) 8(1):39–46Google Scholar
  210. 210.
    Horiguchi A, Ito K, Sumitomo M, Kimura F, Asano T, Hayakawa M (2008) Decreased serum adiponectin levels in patients with metastatic renal cell carcinoma. Jpn J Clin Oncol 38(2):106–111PubMedGoogle Scholar
  211. 211.
    Horiguchi A, Sumitomo M, Asakuma J, Asano T, Zheng R, Nanus DM, Hayakawa M (2006) Increased serum leptin levels and over expression of leptin receptors are associated with the invasion and progression of renal cell carcinoma. J Urol 176(4 Pt 1):1631–1635PubMedGoogle Scholar
  212. 212.
    Pinthus JH, Kleinmann N, Tisdale B, Chatterjee S, Lu JP, Gillis A, Hamlet T, Singh G, Farrokhyar F, Kapoor A (2008) Lower plasma adiponectin levels are associated with larger tumor size and metastasis in clear-cell carcinoma of the kidney. Eur Urol 54(4):866–873PubMedGoogle Scholar
  213. 213.
    Rasmuson T, Grankvist K, Jacobsen J, Olsson T, Ljungberg B (2004) Serum insulin-like growth factor-1 is an independent predictor of prognosis in patients with renal cell carcinoma. Acta Oncol 43(8):744–748PubMedGoogle Scholar
  214. 214.
    Spyridopoulos TN, Petridou ET, Skalkidou A, Dessypris N, Chrousos GP, Mantzoros CS (2007) Low adiponectin levels are associated with renal cell carcinoma: a case-control study. Int J Cancer 120(7):1573–1578PubMedGoogle Scholar
  215. 215.
    Iimura Y, Saito K, Fujii Y, Kumagai J, Kawakami S, Komai Y, Yonese J, Fukui I, Kihara K (2009) Development and external validation of a new outcome prediction model for patients with clear cell renal cell carcinoma treated with nephrectomy based on preoperative serum C-reactive protein and TNM classification: the TNM-C score. J Urol 181(3):1004–1012, discussion 1012PubMedGoogle Scholar
  216. 216.
    Dupont J, Le Roith D (2001) Insulin-like growth factor 1 and oestradiol promote cell proliferation of MCF-7 breast cancer cells: new insights into their synergistic effects. Mol Pathol 54(3):149–154PubMedPubMedCentralGoogle Scholar
  217. 217.
    Hamelers IH, Steenbergh PH (2003) Interactions between estrogen and insulin-like growth factor signaling pathways in human breast tumor cells. Endocr Relat Cancer 10(2):331–345PubMedGoogle Scholar
  218. 218.
    Poretsky L, Kalin MF (1987) The gonadotropic function of insulin. Endocr Rev 8(2):132–141PubMedGoogle Scholar
  219. 219.
    Pugeat M, Crave JC, Elmidani M, Nicolas MH, Garoscio-Cholet M, Lejeune H, Dechaud H, Tourniaire J (1991) Pathophysiology of sex hormone binding globulin (SHBG): relation to insulin. J Steroid Biochem Mol Biol 40(4–6):841–849PubMedGoogle Scholar
  220. 220.
    LeRoith D, Werner H, Beitner-Johnson D, Roberts CT Jr (1995) Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev 16(2):143–163PubMedGoogle Scholar
  221. 221.
    Maor S, Papa MZ, Yarden RI, Friedman E, Lerenthal Y, Lee SW, Mayer D, Werner H (2007) Insulin-like growth factor-I controls BRCA1 gene expression through activation of transcription factor Sp1. Horm Metab Res 39(3):179–185PubMedGoogle Scholar
  222. 222.
    Hotamisligil GS, Shargill NS, Spiegelman BM (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259(5091):87–91PubMedGoogle Scholar
  223. 223.
    Purohit A, Newman SP, Reed MJ (2002) The role of cytokines in regulating estrogen synthesis: implications for the etiology of breast cancer. Breast Cancer Res 4(2):65–69PubMedPubMedCentralGoogle Scholar
  224. 224.
    Gonullu G, Ersoy C, Ersoy A, Evrensel T, Basturk B, Kurt E, Oral B, Gokgoz S, Manavoglu O (2005) Relation between insulin resistance and serum concentrations of IL-6 and TNF-alpha in overweight or obese women with early stage breast cancer. Cytokine 31(4):264–269PubMedGoogle Scholar
  225. 225.
    Vozarova B, Weyer C, Hanson K, Tataranni PA, Bogardus C, Pratley RE (2001) Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes Res 9(7):414–417PubMedGoogle Scholar
  226. 226.
    Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R (2002) Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun 290(3):1084–1089PubMedGoogle Scholar
  227. 227.
    Gaudet MM, Falk RT, Gierach GL, Lacey JV Jr, Graubard BI, Dorgan JF, Brinton LA (2010) Do adipokines underlie the association between known risk factors and breast cancer among a cohort of United States women? Cancer Epidemiol 34(5):580–586PubMedPubMedCentralGoogle Scholar
  228. 228.
    Tworoger SS, Mantzoros C, Hankinson SE (2007) Relationship of plasma adiponectin with sex hormone and insulin-like growth factor levels. Obesity (Silver Spring) 15(9):2217–2224Google Scholar
  229. 229.
    Wildman RP, Wang D, Fernandez I, Mancuso P, Santoro N, Scherer PE, Sowers MR (2012) Associations of testosterone and sex hormone binding globulin with adipose tissue hormones in midlife women. Obesity (Silver Spring) 21:629–636Google Scholar
  230. 230.
    Szymanska E, Bouwman J, Strassburg K, Vervoort J, Kangas AJ, Soininen P, Ala-Korpela M, Westerhuis J, van Duynhoven JP, Mela DJ, Macdonald IA, Vreeken RJ, Smilde AK, Jacobs DM (2012) Gender-dependent associations of metabolite profiles and body fat distribution in a healthy population with central obesity: towards metabolomics diagnostics. OMICS 16(12):652–667PubMedGoogle Scholar
  231. 231.
    Wells JC (2012) Ethnic variability in adiposity, thrifty phenotypes and cardiometabolic risk: addressing the full range of ethnicity, including those of mixed ethnicity. Obes Rev 13(Suppl 2):14–29PubMedGoogle Scholar
  232. 232.
    Muller MJ, Lagerpusch M, Enderle J, Schautz B, Heller M, Bosy-Westphal A (2012) Beyond the body mass index: tracking body composition in the pathogenesis of obesity and the metabolic syndrome. Obes Rev 13(Suppl 2):6–13PubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2014

Authors and Affiliations

  1. 1.EpidStat Institute2100 Commonwealth Blvd, Suite 203Ann ArborUSA
  2. 2.Division of Epidemiology, Department of MedicineVanderbilt-Ingram Cancer CenterNashvilleUSA

Personalised recommendations